Physician

Tejas P Patel, M.D.

According to 2025 Medicare claims, Tejas Patel, M.D. (NPI: 1700061736) practices cardiology in the Odessa, TX market, with the plurality of this provider's patient population coming from Ector, TX. This provider's primary affiliated billing organization is MCH PROFESSIONAL CARE (NPI: 1649391269; TIN: 92-0192097) and primary practice location at 79761-5001. Patel is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,002 traditional Medicare patients, billed 5,818 HCPCS/CPT codes, and received $242,948 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 5,633 prescription claims across 888 beneficiaries totaling $862,795 in drug costs, led by Eliquis (Apixaban). 2021 DME data shows 22 claims. Open Payments data shows 16 records totaling $259. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $56,557 to $862,795. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,532	5,931	$193,174
2016	2,712	6,684	$225,450
2017	2,901	6,725	$203,594
2018	2,604	6,609	$224,829
2019	2,435	6,516	$247,209
2020	2,136	5,692	$213,984
2021	2,209	6,102	$259,359
2022	2,083	5,922	$255,124
2023	2,044	5,707	$239,508
2024	2,002	5,818	$242,948

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	246	1,112	$56,557
2016	378	2,356	$120,232
2017	445	2,573	$177,205
2018	495	2,723	$201,859
2019	526	2,932	$256,214
2020	557	3,356	$383,432
2021	610	3,707	$520,406
2022	747	4,516	$669,641
2023	770	5,066	$840,119
2024	888	5,633	$862,795

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	22	$1,014
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	650	1,012	$82
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	180	455	$60
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	550	591	$49
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	216	250	$10
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	1,196	2,182	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	529	26,606	$502,517
Entresto	Sacubitril/Valsartan	144	5,300	$114,031
Multaq	Dronedarone Hcl	70	2,640	$67,760
Xarelto	Rivaroxaban	51	2,550	$46,374
Repatha Sureclick	Evolocumab	31	1,374	$27,101

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	16	$259	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Tejas P. Patel, M.D.?

Tedicare shows public-source Medicare data for Tejas P. Patel, M.D. (NPI 1700061736), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Tejas P. Patel, M.D. have ACO affiliation data?

Tejas P. Patel, M.D. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Tejas P. Patel, M.D.?

Tejas P. Patel, M.D. is linked to MCH PROFESSIONAL CARE (billing NPI 1649391269) in the available physician profile data.

Does Tejas P. Patel, M.D. have Open Payments data?

Tejas P. Patel, M.D. has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.